{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:19:18Z","timestamp":1790083158711,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001588","name":"Enterprise Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtm.2024.101292","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T16:55:23Z","timestamp":1719248123000},"page":"101292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Highly branched poly \u03b2-amino ester\/CpG-depleted CFTR plasmid nanoparticles for non-viral gene therapy in lung cystic fibrosis disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Bei","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar\u00edo","family":"Manzanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Terreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5053-0611","authenticated-orcid":false,"given":"Wenxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lara-S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101292_bib2","series-title":"ECFSPR Annual Report 2020","author":"Annalisa Orenti","year":"2022"},{"key":"10.1016\/j.omtm.2024.101292_bib4","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101292_bib5","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2024.101292_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.201404-0670OC","article-title":"A Functional Anatomic Defect of the Cystic Fibrosis Airway","volume":"190","author":"Birket","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2024.101292_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101292_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.omtm.2024.101292_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5863\/1551-6776-25.3.192","article-title":"Elexacaftor-Tezacaftor-Ivacaftor: The First Triple-Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulating Therapy","volume":"25","author":"Ridley","year":"2020","journal-title":"J.\u00a0Pediatr. Pharmacol. Therapeut."},{"key":"10.1016\/j.omtm.2024.101292_bib10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(23)01608-2","article-title":"The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches","volume":"402","author":"Graeber","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2024.101292_bib11","first-page":"CD010966","article-title":"Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)","volume":"12","author":"Southern","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.omtm.2024.101292_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/hum.2015.027","article-title":"Cystic Fibrosis Gene Therapy in the UK and Elsewhere","volume":"26","author":"Griesenbach","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101292_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/genes9110538","article-title":"Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward","volume":"9","author":"Cooney","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.omtm.2024.101292_bib14","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1089\/10430349950016384","article-title":"A Phase I Study of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to a Lung Segment of Individuals with Cystic Fibrosis","volume":"10","author":"Zuckerman","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101292_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","article-title":"Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer","volume":"37","author":"Arjomandnejad","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2024.101292_bib16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.omtm.2024.101292_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101292_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijpharm.2017.03.094","article-title":"PEGylated composite nanoparticles of PLGA and polyethylenimine for safe and efficient delivery of pDNA to lungs","volume":"524","author":"Kolte","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtm.2024.101292_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0168-3659(01)00397-2","article-title":"Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA","volume":"75","author":"Perez","year":"2001","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtm.2024.101292_bib20","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.2147\/IJN.S321329","article-title":"Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles","volume":"16","author":"Piperno","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.omtm.2024.101292_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtm.2024.101292_bib22","doi-asserted-by":"crossref","first-page":"e1805116","DOI":"10.1002\/adma.201805116","article-title":"Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtm.2024.101292_bib23","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1021\/ja0015388","article-title":"Degradable Poly(\u03b2-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA","volume":"122","author":"Lynn","year":"2000","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omtm.2024.101292_bib24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.mt.6300132","article-title":"Rapid Optimization of Gene Delivery by Parallel End-modification of Poly(\u03b2-amino ester)s","volume":"15","author":"Zugates","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101292_bib25","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101292_bib26","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1038\/s41467-019-11190-0","article-title":"Highly branched poly(\u03b2-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101292_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt1399","article-title":"CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression","volume":"26","author":"Hyde","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101292_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/mt.2011.196","article-title":"Optimization of hCFTR Lung Expression in Mice Using DNA Nanoparticles","volume":"20","author":"Padegimas","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101292_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.omtm.2021.02.020","article-title":"Increased CFTR expression and function from an optimized lentiviral vector for cystic fibrosis gene therapy","volume":"21","author":"Marquez Loza","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101292_bib30","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/ijms19041220","article-title":"Assembly and Functional Analysis of an S\/MAR Based Episome with the Cystic Fibrosis Transmembrane Conductance Regulator Gene","volume":"19","author":"De Rocco","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2024.101292_bib31","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1021\/jacs.3c04191","article-title":"3D Macrocyclic Structure Boosted Gene Delivery: Multi-Cyclic Poly(\u03b2-Amino Ester)s from Step Growth Polymerization","volume":"145","author":"Li","year":"2023","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omtm.2024.101292_bib32","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.3390\/nano12213892","article-title":"Hyperbranched Poly(\u03b2-amino ester)s (HPAEs) Structure Optimisation for Enhanced Gene Delivery: Non-Ideal Termination Elimination","volume":"12","author":"Li","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.omtm.2024.101292_bib33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/bc034067y","article-title":"Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery","volume":"14","author":"Akinc","year":"2003","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.omtm.2024.101292_bib34","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1039\/C5CC02193F","article-title":"Tailoring highly branched poly(\u03b2-amino ester)s: a synthetic platform for epidermal gene therapy","volume":"51","author":"Huang","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.omtm.2024.101292_bib35","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/acs.biomac.5b00966","article-title":"Highly Branched Poly(\u03b2-Amino Esters): Synthesis and Application in Gene Delivery","volume":"16","author":"Cutlar","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.omtm.2024.101292_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0992-21","article-title":"Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis","volume":"2","author":"Johnson","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2024.101292_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jgm.483","article-title":"Efficient transfection of non-proliferating human airway epithelial cells with a synthetic vector system","volume":"6","author":"Meng","year":"2004","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2024.101292_bib38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/17425247.2020.1796628","article-title":"Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities","volume":"17","author":"Karlsson","year":"2020","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.omtm.2024.101292_bib39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/gt.2008.105","article-title":"Gene therapy progress and prospects: synthetic polymer-based systems","volume":"15","author":"Schaffert","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101292_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1039\/D2LC00744D","article-title":"A new microfluidic platform for the highly reproducible preparation of non-viral gene delivery complexes","volume":"23","author":"Protopapa","year":"2022","journal-title":"Lab Chip"},{"key":"10.1016\/j.omtm.2024.101292_bib41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature05062","article-title":"Control and detection of chemical reactions in microfluidic systems","volume":"442","author":"DeMello","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101292_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.resp.2018.11.003","article-title":"Mice-to-men comparison of inhaled drug-aerosol deposition and clearance","volume":"260","author":"Kolanjiyil","year":"2019","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.omtm.2024.101292_bib43","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/mt.2008.96","article-title":"Enhanced Lung Gene Expression After Aerosol Delivery of Concentrated pDNA\/PEI Complexes","volume":"16","author":"Davies","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101292_bib44","series-title":"Nonviral Vectors for Gene Therapy","first-page":"225","article-title":"Lyophilization of Nonviral Gene Delivery Systems","author":"Allison","year":"2001"},{"key":"10.1016\/j.omtm.2024.101292_bib45","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1016\/j.biomaterials.2012.06.009","article-title":"CpG-free plasmid expression cassettes for cystic fibrosis gene therapy","volume":"33","author":"Pringle","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2024.101292_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312774","article-title":"Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2024.101292_bib47","series-title":"Cystic Fibrosis Diagnosis and Protocols Volume I: Approaches to Study and Correct CFTR Defects","first-page":"39","article-title":"Use of Primary Cultures of Human Bronchial Epithelial Cells Isolated from Cystic Fibrosis Patients for the Pre-clinical Testing of CFTR Modulators","author":"Neuberger","year":"2011"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T17:55:43Z","timestamp":1733507743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124001086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2329050124001086"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101292","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly branched poly \u03b2-amino ester\/CpG-depleted CFTR plasmid nanoparticles for non-viral gene therapy in lung cystic fibrosis disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101292"}}